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Abstract
Objective: To date numerous attempts have been undertaken to conquer the challenging problem of reconstructing long segmental
tracheal defects, as yet without lasting success. Recently, employing concepts of tissue engineering in animals, cartilage-like constructs were
transplanted in vivo. However, both the feasibility of fabricating tracheal replacements and the use of human tracheal chondrocytes (HTC)
for tissue engineering are still under investigation. In this study, we optimized isolation and cultivation techniques for human tracheal
cartilage, assessing the feasibility of seeding these cells onto a novel, three-dimensional (3-D) polyester-urethane polymer (DegraPolw).
Methods: Human tracheal cartilage was harvested from the trachea of lung donors, digested in 0.3% collagenase II, and the condrocytes
serially passaged every 7–9 days. Cells were also cultivated over agar plate during the total 6–8 weeks expansion phase. Thereafter,
chondrocytes were seeded onto DegraPolw (pore sizes 150–200 mm) with a seeding density of 2:4 £ 107=ml, and chondrocyte-polymer
constructs maintained during in vitro static culture. Results: HTC displayed stable proliferation kinetics in monolayer culture with positive
expression of collagen type II. Following polymer seeding, both cellular proliferation and extracellular matrix (ECM) production, as
measured by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) and glycosaminoglycan assays, continued over extended
culture. Active growth of HTC on DegraPolw was further demonstrated by Alcian blue staining, with the histomorphological appearance of
the construct resembling that of native cartilage. Scanning electron microscopy showed chondrocyte growth and ECM synthesis both on the
surface and inside the porous scaffold, with a dense cell layer on the surface of the scaffold and a lower cell distribution in the scaffold’s
interior. Conclusions: The harvested chondrocytes from human trachea cartilage expand well in vitro and possess the ability to form new
cartilage-like tissue when seeded onto DegraPolw matrix. However, improved culture conditions are needed to permit cellular growth
throughout cell–polymer constructs.
q 2003 Elsevier Science B.V. All rights reserved.
Keywords: Tissue engineering; Human trachea chondrocyte; DegraPolw
1. Introduction
During the past 50 years, several attempts have been
made to cope with the challenging problems of reconstruct-
ing long segmental tracheal defects. End-to-end anasto-
mosis is still the most widely applied surgical procedure
after tracheal resection. However, extensive tracheal defects
comprising more than 40–50% of the total length of the
trachea require the use of grafting techniques [1]. To solve
the problem of bridging long tracheal defects, several
attempts have been made both clinically and experi-
mentally, including the use of prostheses, autografts, and
allografts [2]. Due to infection, extrusion, obstruction,
stenosis and chronic rejection [1–3], replacement of
substantial tracheal defects remains a challenge in con-
temporary thoracic surgery.
The advances in tissue engineering during the past decade
[4–7] have opened a new approach toward the concept of
functional tissue substitutes. To recreate cartilaginous tissue,
a high-density chondrocyte solution is seeded onto a
customized biocompatible and/or biodegradable scaffold.
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While the parameters of the cellular components are limited
by the nature of their source, intensive research has been
focussed on the design of the ideal bed. Polymer scaffolds
provide a three-dimensional (3-D) microenvironment which
allows chondrocytes to anchor, permits exchange of gas and
nutrients, and promotes the synthesis of extracellular matrix
(ECM). Tracheal reconstruction based on tissue engineered
constructs has been attempted by only a few groups [8–10].
Small chondrocyte–polymer patch contructs sutured into
rabbit trachea have been shown to maintain structural
architecture and intact epithelization for 6 weeks [10].
Survival for up to 1 week could be achieved by using seeded
polyglycolic acid (PGA) cartilage-like cylindrical scaffolds
to bridge tracheal defects in athymic rats, before the grafts
stenosed [8]. Recently, employing a complex helical
windpipe design, Kojima et al. were able to successfully
reconstruct circumferential tracheal defects in sheep and
keep them patent for up to 7 days [9]. Although these data
support the concept of employing tissue engineered con-
structs for the replacement of tracheal defects, its clinical
applicability is hampered by several obstacles. First,
extensive research is being devoted toward improving
artificial matrices, however, the ideal scaffold has yet to be
designed. A novel biocompatible, degradable and porous
polyesterurethane polymer (DegraPolw) has recently been
shown to be a favorable scaffold for rat chondrocyte adhesion
and cultivation [11]. Second, the knowledge on the specific
in vitro characteristics of chondrocytes from different
anatomical sites is fragmentary. Theoretically, chondrocytes
isolated from tracheal cartilage should serve as an ideal cell
source for fabricating artificial tracheal constructs. Interest-
ingly, human tracheal chondrocytes (HTC) isolated from
human trachea have never been analyzed for this purpose.
In this study we investigated the feasibility of culturing
chondrocytes from human tracheal cartilage on DegraPolw
scaffold in vitro.
2. Materials and methods
2.1. Chondrocyte isolation and expansion
Human tracheal cartilage segments were harvested from
the trachea or the main bronchus of donor lungs for lung
transplantation (donor age ranged from 28 to 39 years).
Immediately after surgery, samples were put into transport
Ham’s F12 (PAN Biotech, Germany) solution containing
200 mg/ml gentamycin (PAN Biotech) and 0.5 mg/ml
amphotericin (PAN Biotech). The perichondrium was
removed under sterile conditions to prevent contamination
with fibroblasts. Minced cartilage particle were then
digested with 0.3% collagenase II (PAN Biotech) solution
in fresh F12 at 37 8C for 16–18 h. The resulting suspension
was centrifuged at 400 £ g for 5 min and the chondrocyte
pellets resuspended in Ham’s F12 medium with 146 mg/l
L-glutamine, 50 mg/ml of gentamycin, and 10% fetal bovine
serum (PAN Biotech). Chondrocytes were plated onto
75-cm2 vented polystyrene cell culture flasks (Costar 3376,
Corning Inc., Corning, NY, USA) and supported in a
humidified incubator at 37 8C with 5% CO2. Medium was
changed twice a week. Cells were trypsinized using
trypsin/EDTA solution (0.05%/0.02%, PAN Biotech) for
2–5 min at 37 8C and serially passaged after reaching
confluency. After the third or fourth passage, cells were
collected and cultivated over 1% agar plates for 4 days to
exclude contaminating fibroblast and to restimulate ECM
secretion in chondrocytes. Following the agar-plating, cells
were collected again in flasks and seeded on polymer when
completing the 6th–8th passage.
2.2. Preparation of polymer scaffold
DegraPolw, a biodegradable, porous and elastic poly-
esterurethane foam, was processed into an open porous
structure through a freeze-precipitation technique as
previously described [12] The scaffolds obtained in this
way had pore sizes in the range of 150–200 mm. DegraPolw
strips ð20 £ 5 £ 1 mm) were prepared and sterilized with
ethylene oxide. Prior to use, the scaffolds were moistened
with distilled water and degassed under vacuum.
2.3. Cell seeding and in vitro static culture
Chondrocytes were trypsinized from culture flasks and
suspended to create a single cell suspension. After washing,
a seeding solution of 2:4 £ 107=ml was created and 0.1 ml
was distributed onto a DegraPolw strip in the bottom of a
polystyrene six-well flat-bottomed culture plate. Allowing
for complete attachement, after 2 h, medium was changed
and culture conditions maintained at 37 8C with 5% CO2.
2.4. Collagen type II expression
Qualitative expression of collagen type II protein was
analyzed before seeding. Cells in solution were plated on a
small slide for 16 h and fixed with 4% phosphate buffered
formalin. A two-step indirect immunoenzymatic staining
method was employed. Incubation with rabbit anti-rat
collagen II polyclonal antibody (1:100, Chemicon Inc.,
USA) was carried out overnight at 4 8C followed by a 3-h
incubation of peroxidose-labelled anti-rabbit immuno-
globulin (1:200) at room temperature. Stains without first
antibody of control specimens were also performed.
2.5. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) assay for testing cell growth
MTT assay determines viable cell numbers and is based
on the mitochondrial conversion of the tetrazolium salt,
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide (MTT). Briefly, a modified assay was employed to
quantitatively assess the viable chondrocytes growing on
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the scaffolds [13]. 5 £ 104 cells in 0.1 ml F12 were seeded
on each DegraPolw disc (10 mm in diameter and 1 mm in
thickness) and placed in a 24-well culture plate. At different
time points (2 h, and 3, 7, 21, and 42 days), 250 ml medium
and 20 ml MTT solution were added to each well, incubated
at 37 8C for 1 h, and the supernatant discarded and replaced
by 400 ml isopropanol with 10% formic acid. Samples were
incubated at 37 8C for an additional 5 min, vortexed for
10 min, and the MTT absorbency values of the resulting
solution measured using an ELISA reader (Dynatech 5000,
Dynatech, Billinghurst, UK) at a wavelength of 570 nm.
2.6. Glycosaminoglycan (GAG) content test
Samples of engineered chondrocyte-DegraPolw con-
structs were frozen, lyophilized, and digested with papain
type III (Sigma) solution (25 mg/ml) containing 0.1 M
NaH2PO4, 5 mM EDTA, 5 mM cysteine HCl at 56 8C for
15 h. Sulfated glycosaminoglycan content was determined
spectrophotometrically at 590 nm wavelength after reaction
with dimethylmethylene blue by using bovine chondroitin
sulfate (Sigma, St. Louis, MO, USA) as a standard.
Glycosaminoglycan was measured in mg/ml reported as a
percentage of dry weight [14].
2.7. Histological and scanning electron microscopy (SEM)
analysis
Samples were fixed for histological analysis with 4%
phosphate-buffered formalin, embedded in paraffin and
sectioned using standard histochemical techniques. Slide
sections were stained with Alcian blue for chondroitin
sulfate. Samples for SEM examination were fixed in 2%
phosphate-buffered glutaraldehyde solution, then dehy-
drated with a graded isopropanol series and air dried.
Before analysis, the dried samples were mounted on
alminum supports and sputter-coated with gold.
2.8. Statistics
The data shown were expressed as mean ^ standard
deviation. We used SPSS 8.0 software for statistical
analysis. An unpaired t-test was performed, considering a
P-value of less than 0.05 as statistically significant.
3. Results
3.1. Successful cultivation and expansion of HTC
Following collagenase digestion and flask-culturing,
HTC underwent a morphological change toward an
elongated, fibroblast-like appearance in the 2-D environ-
ment. Each monolayer passage led to a two- to threefold
increase in cell numbers. When HTC were then seeded onto
agar plates, cells regained their spherical morphology as
observed in all the cultures from various donors (n ¼ 9) by
in vitro microscopy. During both cultivation modi, HTC
constantly stained positive for the expression of collagen
type II (Fig. 1).
3.2. Dynamic growth patterns displayed by
DegraPolw-seeded HTC
After seeding of the constructs, assessment of chondrocyte-
DegraPolw in vitro static culture through MTT test showed
viable chondrocyte proliferation (Fig. 2). Compared with 2 h
culture (MTT absorbency values ¼ 0:112 ^ 0:004), absor-
bency value of MTT increased significantly to 0.176 ^ 0.023
at 21 days, and to 0.213 ^ 0.023 at 42 days, respectively
(P , 0:05). Testing for GAG contents of constructs displayed
a constant GAG increase up to 53 and 84% at 21 and 42 days,
respectively, compared to day-3-culture values (Fig. 3).
3.3. Fabrication of a cartilage-like microstructure in
HTC–DegraPolw constructs
When seeded onto 3-D DegroPolw, HTC readily adhered
to the polymer in multiple layers and regained a rounded
configuration similar to the spherical appearance of
chondrocytes in native cartilage, as observed with contrast
phase microscope. Histological gross examination revealed
a cartilage-like appearance of the HTC-seeded DegraPolw
constructs, and Alcian blue staining demonstrated intra-
construct chondroitinsulfate production (Fig. 4).
SEM pictures revealed that chondrocytes readily grow on
the construct surface and into the open pores of the scaffold.
Cells located on the surface of the scaffold showed
fibroblast-like morphology with high numbers of cell-cell
interactions. In contrast, cells located inside the scaffold
demonstrated a different morphology with a rounded
appearance and a less intimate cell-polymer attachment.
Although sparsely, a 3-D network of thin collagen type II
Fig. 1. Immunohistochemical staining of HTC staining positive for collagen
type II expression after 6–8 weeks in vitro monolayer and agar culture.
Original magnification £100.
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fibrils nevertheless occurred, and tethered the HTC within
the DegraPolw pores (Fig. 5) [15].
4. Discussion
This is the first report to our knowledge on the feasibility
of employing HTC in a concept of tissue engineering in
neo-tracheal constructs.
Although chondrocytes isolated from varying sources
have been successfully seeded onto different scaffolds, little
attention has been focused on correlating anatomical origin
of the cartilage with the functional requirements of the
fabricated design. Several studies have investigated the
ex vivo regeneration of cartilage from isolated human septal
[16], auricular [17,18], and articular chondrocytes [19], yet,
physiological properties of the cells differ substantially in
regard to their anatomic origin. Cellular doubling times of
human septal chondrocytes, for example, comprise 2.6 days
[16], in contrast to 10 days in cultures of human auricular
cartilage cells [17]. Chondrocyte viability of human
auricular after isolating was approximately 85% determined
by a hemocytometer and trypan blue vital dye [17], yet,
isolation efficacy of human septal chondrocytes was only
11.9% as determined by DNA assay [16]. Given the
observed inter-tissue differences within the same species,
and especially in attempting to recreate the complex
functionality of the trachea, the anatomical origin of the
cells employed will very likely influence the long time
success of the tissue engineered replacement. Therefore,
and in view of a subsequent in vivo employment, we
explored the practicability of culturing HTC.
When placed in a 2-D culture milieu, chondrocytes
characteristically undergo a process of de-differentiation: in
addition to taking on a fibroblast-like shape, they loose their
ability to secrete proteoglycans, and change from collagen
type II to type I production [20]. The resulting matrix has
inferior mechanical properties and lacks the functionality
initially displayed at its original anatomical site. Yet,
this loss of diversity can be reversed through cultivation in a
3-D medium, such as agarose, where chondrocytes regain
spherical configuration and recover original matrix secre-
tion patterns [21]. Restoration of spherical shape reflects a
differentiated chondrocyte phenotype [20] and correlates
with high fractions of collagen type II and the absence of
collagen type I in tssue-engineered cartilage [15]. Collagen
type II, interconnected with collagen type IX, is crucial in
maintaining the internal framework of hyaline cartilage,
thus preserving its shape, tensile strength and counter-
balancing proteoglycan swelling pressure. Anderer et al.
observed the re-expression of collagen type II in chondro-
cytes cultured as spheroids during prolonged monolayer
passages [19], and Rodriguez et al. were able to document
Fig. 2. MTT absorbency values at 570 nm showing viable HTC
proliferation after seeding onto DegraPolw discs and in vitro static culture.
Fig. 3. GAG content assay displayed an increase of GAG concentration in
cell-polymer constructs over time.
Fig. 4. Three weeks after seeding of HTC onto DegraPolw and in vitro static
culture. Alcian blue staining displays a histomorphological architecture
resembling native cartilage. Original magnification £100.
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the same phenomenon in cultures of human ear chondro-
cytes beyond the fourth week of passaging [17]. In our
experiments, we observed the same phenomenon, where
HTC cultured on agar plates re-expressed collagen type II
after 6–8 weeks. Obviously, the process of re-acquiring the
former phenotype in terms of shape and synthesis patterns
reflects a cell-specific reconstitution. However, quality and
duration of this phenotypic change, especially in vastly
expanded cell groups, have to be assessed in vivo. Possibly,
following implantation the host of environmental stimuli
Fig. 5. Scanning electron micrographs (A,C: exterior; B,D,E,F: interior). (A,B) Plain DegraPolw scaffold. (C,D) ECM synthesis 3 weeks after HTC were seeded
onto DegraPolw strips. Note that chondrocytes retained their spherical configuration, suggesting a well-differentiated phenotype. (E) Although sparsely, a 3-D
network of thin collagen type II fibrils occurred in constructs at 3 weeks after seeding onto DegraPolw. (F) In comparison, 3-D network of collagen type II
fibrils in native human trachea cartilage.
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toward reconstituted HTC may support their further
re-differentiation.
In addition, we also assessed the growth dynamics of
isolated HTC in 3-D DegroPolw scaffold. Expanding our
initial experiments and transferring HTC from a 2-D into a
3-D environment, they were able to retain their state of
phenotypical reconstitution, thereby repopulating the poly-
meric matrix. The fabricated construct resembled native
cartilage both histologically and in SEM. Cellular distri-
bution and attachment to the matrix during in vitro static
culture are determined by gravity [22], and the spatially
uniform distribution reflects porosity and surface charge of
the scaffold. Attach rates for HTC to DegraPolw were 80%
in comparison to the monolayer culture, with highest celluar
densities on the construct surface. Although HTC with
adjacent, well-spaced ECM frameworks could be detected
within the central pores of the polymer, overall cellular
concentrations diminished with distance from the surface.
Probably, in static in vitro culture, gas exchange and
diffusion of nutrients limit an even distribution of HTC
throughout the construct. To overcome this obstacle,
additional aspect of HTC–polymer cultivation should be
considered. First, especially in regard of fabricating more
massive, tubular designs, dynamic stress stimuli [23,24]
may be beneficial for inducing evenly structured construct
to withstand in vivo mechanical impact. Thus, integration
of a bioreactor with adjustable dynamic stress and shear
stimuli for cultivation might improve the quality of the
cellular growth pattern on/within the constructs. Second,
in vivo conditioning of seeded cell/polymer designs before
orthotopic implantation may serve as a natural bioreactor.
Cell–cell interaction with the host and neovascularization
of the design might improve the quality of the construct.
Taken together, our results demonstrate the successful
harvest, cultivation, expansion and seeding of HTC in a
tissue engineering concept. We have demonstrated that
cultivated chondrocytes from human trachea can populate
DegraPolw, a novel biocompatible, degradable polymer,
developing a cartilage-like histological architecture. In
choosing tracheal chondrocytes for generating an orthotopic
replacement structure, these preliminary results represent a
basis for further research in the field. Employing tubular
polymer designs, in vitro dynamic stimuli and/or in vivo
conditioning, promising approaches for future design of a
functional tracheal replacement can be envisioned.
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